GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ADMA · Dec 31, 2024

ADMA BIOLOGICS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001140361-25-009257General Corporate
Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.93% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

27.83% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

39.92% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

51.48% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

32.59% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

0.43% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

3.19% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History10 statesHistory building
Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/9 normalizedLevel 3Dec 31, 20250/9 normalizedLevel 3Mar 31, 20267/9 normalizedLevel 3Jun 30, 20267/9 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.88%
Current
1.93%
Delta
1.05%
Cash Generation Increased
Previous
20.88%
Current
27.83%
Delta
6.94%
Inventory Pressure Decreased
Previous
143.36%
Current
39.92%
Delta
-103.44%
Margin Increased
Previous
49.78%
Current
51.48%
Delta
1.70%
Profitability Decreased
Previous
33.08%
Current
32.59%
Delta
-0.49%
R And D Intensity Increased
Previous
0.34%
Current
0.43%
Delta
0.08%
Sbc Intensity Increased
Previous
2.65%
Current
3.19%
Delta
0.54%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ADMA Fundamental State →Transitioned To · ADMA Fundamental State →Transitioned To · ADMA CAPEX_INTENSITY_INCREASED →Transitioned To · ADMA CASH_GENERATION_INCREASED →Transitioned To · ADMA INVENTORY_PRESSURE_DECREASED →Transitioned To · ADMA MARGIN_INCREASED →Transitioned To · ADMA PROFITABILITY_DECREASED →Transitioned To · ADMA R_AND_D_INTENSITY_INCREASED →Transitioned To · ADMA SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.